Sandoval's Delayed Return Resets Red Sox Ceiling as Boston Extends Winning Streak
By Erik Schwartz ·
Boston's sudden surge masks a rotation vulnerability that Patrick Sandoval's injury recovery may not fully solve before the All-Star break.
The Red Sox notched their sixth consecutive win Thursday in Chicago, a 2-1 victory over the White Sox that capped a flawless 4-0 road trip and moved Boston to 43-48, within five games of .500 for the first time since May 20. The real news, however, arrived in the fourth inning when Patrick Sandoval took the mound for his first MLB appearance since June 21, 2024 — nearly two years removed from Tommy John surgery and more than 18 months into his two-year Red Sox contract. That gap alone tells you something: this was never a plug-and-play acquisition. Sandoval delivered a serviceable outing, scattering five hits and one run across 4 1/3 innings with five strikeouts against minimal walks (one), working 65 pitches with 41 strikes. Boston's offense, meanwhile, leaned on Caleb Durbin's two-run homer in the fourth and Jarren Duran's diving, 94-foot catch in the eighth—the kind of peripheral wins that feel durable only when pitching stabilizes.
Context matters here. Boston has won 11 of its last 13 games, a stretch that's genuine but also thin. The rotation has been working around holes all season, and Sandoval's return doesn't immediately fill them—it merely opens a new variable. His 4 1/3 innings suggest a carefully managed ramp-up; expect workload caps to persist through the All-Star break, likely capping him at 75-80 pitches per start for the next two to three outings. That's a pitcher available but not yet reliable, especially in a short-odds playoff race where depth matters enormously.
For bettors, the temptation to ride Boston's six-game streak into the Mets series Friday is real and wrong. The Red Sox have improved their offense—Durbin's eight homers since June 10 are not noise—but they've also benefited from facing weaker competition (Angels sweep, weak White Sox lineup). The Mets, even without their strongest lineup pieces, present a different challenge, and Boston's pitching remains structurally fragile. Sandoval's return is a net positive for the rotation's ceiling but doesn't change its baseline reliability. Boston's team total for games against New York is likely to be priced higher on the strength of the win streak, but the market hasn't yet adjusted for the fact that Sandoval is 4 1/3 innings of future uncertainty, not established performance. Fade overs on Red Sox team totals in the Mets series until Sandoval completes at least two six-inning starts; the market is giving credit for potential rather than production.
The strikeout component is similarly overweighted. Sandoval's five K's in 4 1/3 innings reads cleanly, but context: he faced a White Sox team that ranks in the bottom third in strikeout avoidance. His first real test against a league-average lineup will inform whether his velocity and command have truly recovered from 18 months of rehab. If the market is pricing Sandoval K props as if he's a sub-3.0 ERA starter, you have a short window to fade them before the White Sox sample evaporates.